Exagen, Inc. (XGN)
8.57
-0.13
(-1.49%)
USD |
NASDAQ |
Oct 30, 16:00
8.57
0.00 (0.00%)
After-Hours: 20:00
Exagen Cash and Short Term Investments (Annual) : 32.22M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 32.22M |
| December 31, 2024 | 22.04M |
| December 31, 2023 | 36.49M |
| December 31, 2022 | 62.39M |
| December 31, 2021 | 99.44M |
| December 31, 2020 | 57.45M |
| December 31, 2019 | 72.08M |
| Date | Value |
|---|---|
| December 31, 2018 | 13.16M |
| December 31, 2017 | 11.24M |
| December 31, 2016 | |
| December 31, 2015 | 2.509M |
| December 31, 2014 | 4.605M |
| December 31, 2013 | 7.743M |
| December 31, 2012 | 3.452M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Myriad Genetics, Inc. | 149.60M |
| BioRestorative Therapies, Inc. | 2.953M |
| CareDx, Inc. | 177.21M |
| Natera, Inc. | 1.076B |
| Sera Prognostics, Inc. | 39.20M |